Lifepoint Health, Inc. (LPNT) SEC Filing 10-K Annual report for the fiscal year ending Sunday, December 31, 2017

Exhibit 99.1

LifePoint Health Reports Fourth Quarter and Year-End 2017 Results

Company Issues 2018 Guidance

BRENTWOOD, Tenn.--(BUSINESS WIRE)--February 23, 2018--LifePoint Health, Inc. (NASDAQ: LPNT) today announced results for the fourth quarter and year ended December 31, 2017.

Fourth Quarter 2017

The following highlights the Company’s results of operations as presented in accordance with U.S. generally accepted accounting principles (“GAAP”) for the fourth quarter ended December 31, 2017:

• Same-hospital revenues totaled $1,490.3 million, a decrease of 5.2% compared to the same period last year;
• Net loss totaled $27.0 million;
• Diluted loss per share attributable to LifePoint Health, Inc. stockholders was $0.70; and
• Net cash provided by operating activities totaled $178.2 million, an increase of $75.7 million, or 73.9%, compared to the same period last year.

Included in the Company’s results of operations for the fourth quarter ended December 31, 2017, were the following non-operational adjustments:

• $72.6 million increase recorded to the provision for doubtful accounts, or $1.15 loss per diluted share, as a result of a change in the Company’s accounting estimate of the collectability of accounts receivable identified by the Company’s management during the process of installing new systems and developing enhanced analytical procedures in order to centralize, standardize and refine its estimation processes to more precisely estimate the collectability of accounts receivable at a more detailed and disaggregated level;
• $4.8 million in severance costs, or $0.08 loss per diluted share, associated with a reduction in force at the Company’s corporate headquarters;
• $43.2 million aggregate impairment charges, or $0.69 loss per diluted share, to write-down the carrying values of certain long-lived assets at two of the Company’s hospitals; and
• $18.0 million decrease in the provision for income taxes, or $0.45 earnings per diluted share, related to the estimated impact of the Tax Cuts and Jobs Act on the Company’s deferred tax positions.